Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
China’s Emergence Into the Global Pharma Industry




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: China’s Emergence Into the Global Pharma Industry
Released on: January 20, 2009. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
Recently big pharma have been taking advantage of the financial and industrial environment in China. In this interview Fintan Walton and Dr. Bill Guo, founder and Chairman of Venturepharm, take a look at the evolution of the biopharma industry within China. Dr. Guo speaks of the dramatic changes that China has been experiencing and, as his company rides at the forefront of these changes, the reasons he predicts that China will very shortly be a major player in all aspects of the pharmaceutical industry.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Origin of Venturepharm.
Fintan Walton:
Hello and welcome to PharmaVentures Business Review here in Melbourne, Australia. On this show I have Bill Guo who is the Founder and Chairman of Venturepharm. Welcome to the show.
Bill Guo:
Yeah, good morning.
Fintan Walton:
Bill Guo, you are the founder of the company that was founded in China in 1999.
Bill Guo:
Yeah.
Fintan Walton:
And today you have 2,500 people and you describe yourselves as a pharmaceutical services company or?
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Bill Guo
Chairman
Bill Guo is the Chairman and founder of Venturepharm Group, a leading full service provider to world life science industry. Venturepharm Group now has two public companies, Venturepharm Lab, the first China CRO listed in Hong Kong and CBI, the first Chinese CRO's acquisition of a US CRO in NASDAQ.
Venturepharm
Venturepharm Asia is a global life science leader with a strategic focus on venture capital, merchant banking, CRO, CMO, CSO, compound partnering, and royalty sharing. The group develops an innovative full service plus model to position itself strongly in the life science industry. Currently Venturepharm Asia has more than two thousand employees. Venturepharm is the largest global provider of pharmaceutical development service in China. Venturepharm provides full service of drug discovery and development that take new drugs from "Idea to patients." These include API (Active Pharmaceutical Ingredient), formulation development, clinical trial, product registration, marketing & sales to pharmaceutical distributors and patients in China and overseas.